• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    9/15/23 11:52:24 AM ET
    $PLNT
    $PLRX
    $PMF
    $PML
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PLNT alert in real time by email

     

    Friday's session saw 169 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • Blue Star Foods (NASDAQ:BSFC) was the smallest company in terms of market cap to set a new 52-week low.
    • PTC Therapeutics (NASDAQ:PTCT)'s stock fell the most, as it traded down 31.29% to reach a new 52-week low.
    • Prelude Therapeutics (NASDAQ:PRLD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    On Friday, the following stocks set new 52-week lows:

    • Bristol-Myers Squibb (NYSE:BMY) stock dropped to a yearly low on Friday of $58.92. Shares traded down 0.87%.
    • Realty Income (NYSE:O) shares reached a new 52-week low of $54.29 on Friday morning, moving down 1.42%.
    • Illumina (NASDAQ:ILMN) stock hit a yearly low of $145.14. The stock was down 3.41% for the day.
    • ResMed (NYSE:RMD) stock hit $145.74 on Friday morning, setting a new 52-week low for a change of down 0.98%.
    • Royalty Pharma (NASDAQ:RPRX) shares made a new 52-week low of $28.21 on Friday. The stock was down 1.67% for the day.
    • Insulet (NASDAQ:PODD) stock hit $166.03 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • Chewy (NYSE:CHWY) stock set a new 52-week low of $20.48 on Friday, moving down 2.75%.
    • TKO Group Holdings (NYSE:TKO) shares fell to $99.24 on Friday, setting a new 52-week low with a shift of down 1.27%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a new 52-week low of $141.67. The stock was down 1.29% on the session.
    • Liberty SiriusXM Gr (NASDAQ:LSXMB) shares reached a new 52-week low of $22.19 on Friday morning, moving down 3.38%.
    • Agree Realty (NYSE:ADC) shares set a new 52-week low of $59.51. The stock traded down 0.9%.
    • Envista Holdings (NYSE:NVST) shares made a new 52-week low of $28.74 on Friday. The stock was down 0.62% for the day.
    • Planet Fitness (NYSE:PLNT) stock dropped to a yearly low on Friday of $50.21. Shares traded down 15.17%.
    • Cava Group (NYSE:CAVA) stock broke to a new 52-week low of $34.42 on Friday. Shares of the company traded down 3.66%.
    • Medical Properties Trust (NYSE:MPW) stock achieved a new 52-week low on Friday morning, hitting $6.28 and moving down 3.72%.
    • PNM Resources (NYSE:PNM) stock broke to a new 52-week low of $43.64 on Friday. Shares of the company traded down 0.22%.
    • Savers Value Village (NYSE:SVV) shares fell to $19.61 on Friday, setting a new 52-week low with a shift of down 2.02%.
    • Physicians Realty Trust (NYSE:DOC) shares hit a yearly low of $12.94. The stock was down 3.03% on the session.
    • Macy's (NYSE:M) stock hit $11.15 on Friday morning, setting a new 52-week low for a change of down 1.54%.
    • Tower Semiconductor (NASDAQ:TSEM) stock dropped to a yearly low on Friday of $27.23. Shares traded down 2.22%.
    • Galapagos (NASDAQ:GLPG) stock dropped to a yearly low on Friday of $36.00. Shares traded down 0.11%.
    • PTC Therapeutics (NASDAQ:PTCT) shares set a new yearly low of $24.43 this morning. The stock was down 31.29% on the session.
    • Grupo Televisa (NYSE:TV) stock set a new 52-week low of $3.41 on Friday, moving down 2.01%.
    • Mister Car Wash (NYSE:MCW) shares hit a yearly low of $6.04. The stock was down 1.61% on the session.
    • Peloton Interactive (NASDAQ:PTON) shares hit a yearly low of $4.96. The stock was down 2.43% on the session.
    • Spirit AeroSystems Hldgs (NYSE:SPR) shares were up 1.28% for the day, having made a 52-week low of $16.28.
    • Silicon Motion Technology (NASDAQ:SIMO) shares set a new 52-week low of $50.51. The stock traded down 1.35%.
    • Supernus Pharmaceuticals (NASDAQ:SUPN) shares set a new 52-week low of $28.77. The stock traded down 1.13%.
    • ZIM Integrated Shipping (NYSE:ZIM) shares set a new yearly low of $11.15 this morning. The stock was up 0.45% on the session.
    • Amylyx Pharma (NASDAQ:AMLX) shares set a new yearly low of $19.36 this morning. The stock was up 0.25% on the session.
    • Petco Health and Wellness (NASDAQ:WOOF) stock drifted down 3.78% on Friday morning to hit a new 52-week low of $4.44.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) stock hit a yearly low of $16.76. The stock was down 0.21% for the day.
    • Netstreit (NYSE:NTST) stock broke to a new 52-week low of $16.62 on Friday. Shares of the company traded up 0.3%.
    • Phreesia (NYSE:PHR) stock hit a new 52-week low of $19.52. The stock was down 1.44% on the session.
    • Pliant Therapeutics (NASDAQ:PLRX) shares reached a new 52-week low of $15.82 on Friday morning, moving down 0.56%.
    • Olo (NYSE:OLO) shares set a new 52-week low of $5.63. The stock traded down 0.44%.
    • Definitive Healthcare (NASDAQ:DH) stock set a new 52-week low of $8.07 on Friday, moving down 1.21%.
    • Tekla Healthcare (NYSE:HQH) stock set a new 52-week low of $15.96 on Friday, moving down 0.68%.
    • GDEV (NASDAQ:GDEV) stock achieved a new 52-week low on Friday morning, hitting $3.09 and moving down 9.33%.
    • Gogoro (NASDAQ:GGR) stock drifted down 0.55% on Friday morning to hit a new 52-week low of $2.67.
    • Silk Road Medical (NASDAQ:SILK) stock broke to a new 52-week low of $16.72 on Friday. Shares of the company traded down 1.52%.
    • DocGo (NASDAQ:DCGO) stock drifted down 5.11% on Friday morning to hit a new 52-week low of $5.76.
    • PIMCO Income Strategy (NYSE:PFN) stock broke to a new 52-week low of $6.63 on Friday. Shares of the company traded up 0.15%.
    • FuelCell Energy (NASDAQ:FCEL) stock broke to a new 52-week low of $1.23 on Friday. Shares of the company traded down 3.02%.
    • PIMCO Municipal Income (NYSE:PML) stock achieved a new 52-week low on Friday morning, hitting $8.28 and moving up 0.35%.
    • Nuveen California (NYSE:NKX) stock hit $10.71 on Friday morning, setting a new 52-week low for a change of down 0.28%.
    • Consensus Cloud Solutions (NASDAQ:CCSI) shares set a new yearly low of $25.05 this morning. The stock was down 2.26% on the session.
    • Theravance Biopharma (NASDAQ:TBPH) shares set a new yearly low of $9.05 this morning. The stock was down 5.77% on the session.
    • Lyell Immunopharma (NASDAQ:LYEL) stock set a new 52-week low of $1.66 on Friday, moving down 1.72%.
    • Perfect (NYSE:PERF) stock dropped to a yearly low on Friday of $3.21. Shares traded down 7.28%.
    • Seres Therapeutics (NASDAQ:MCRB) shares moved down 2.2% on Friday to hit a new 52-week low of $2.83, drifting down 2.2%.
    • Eaton Vance Municipal IT (NYSE:EVN) stock hit a yearly low of $9.26. The stock was up 0.22% for the day.
    • Butterfly Network (NYSE:BFLY) shares set a new yearly low of $1.61 this morning. The stock was up 8.57% on the session.
    • Aerovate Therapeutics (NASDAQ:AVTE) stock broke to a new 52-week low of $12.87 on Friday. Shares of the company traded down 5.14%.
    • Materialise (NASDAQ:MTLS) shares fell to $5.96 on Friday, setting a new 52-week low with a shift of down 1.32%.
    • QuantaSing Group (NASDAQ:QSG) shares were down 5.76% for the day, having made a 52-week low of $5.70.
    • TH International (NASDAQ:THCH) stock hit a yearly low of $1.93. The stock was down 2.99% for the day.
    • Expensify (NASDAQ:EXFY) stock set a new 52-week low of $3.56 on Friday, moving down 3.81%.
    • Nuvation Bio (NYSE:NUVB) shares were down 2.17% for the day, having made a 52-week low of $1.33.
    • SkyWater Technology (NASDAQ:SKYT) stock hit a yearly low of $6.06. The stock was down 1.77% for the day.
    • Nuveen Core Plus Impact (NYSE:NPCT) stock hit a new 52-week low of $9.51. The stock was down 0.15% on the session.
    • Citizens Financial Servs (NASDAQ:CZFS) stock broke to a new 52-week low of $49.69 on Friday. Shares of the company traded down 0.14%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $8.92. The stock was down 0.22% on the session.
    • Axogen (NASDAQ:AXGN) shares made a new 52-week low of $5.30 on Friday. The stock was down 2.44% for the day.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $2.28 this morning. The stock was down 2.54% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares made a new 52-week low of $7.43 on Friday. The stock was down 2.86% for the day.
    • Gossamer Bio (NASDAQ:GOSS) stock broke to a new 52-week low of $0.84 on Friday. Shares of the company traded down 1.68%.
    • eGain (NASDAQ:EGAN) shares set a new yearly low of $5.80 this morning. The stock was down 4.13% on the session.
    • Blackrock Investment (NYSE:BKN) shares hit a yearly low of $10.61. The stock was down 0.38% on the session.
    • SIGNA Sports United (NYSE:SSU) shares moved down 6.3% on Friday to hit a new 52-week low of $0.45, drifting down 6.3%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares hit a yearly low of $5.44. The stock was down 0.7% on the session.
    • Prelude Therapeutics (NASDAQ:PRLD) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $3.07.
    • CoreCard (NYSE:CCRD) shares set a new yearly low of $20.01 this morning. The stock was down 0.74% on the session.
    • XIAO-I (NASDAQ:AIXI) shares fell to $2.17 on Friday, setting a new 52-week low with a shift of down 2.01%.
    • Gabelli Healthcare (NYSE:GRX) shares set a new yearly low of $9.10 this morning. The stock was down 0.22% on the session.
    • Skillz (NYSE:SKLZ) stock dropped to a yearly low on Friday of $6.32. Shares traded down 0.93%.
    • Zentek (NASDAQ:ZTEK) stock dropped to a yearly low on Friday of $1.19. Shares traded up 3.23%.
    • Lazydays Hldgs (NASDAQ:LAZY) shares set a new yearly low of $9.13 this morning. The stock was down 8.46% on the session.
    • Flaherty & Crumrine Prefd (NYSE:PFD) stock achieved a new 52-week low on Friday morning, hitting $9.41 and moving up 0.53%.
    • China Automotive Systems (NASDAQ:CAAS) stock drifted down 3.09% on Friday morning to hit a new 52-week low of $3.67.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock dropped to a yearly low on Friday of $1.29. Shares traded up 2.29%.
    • Honest Co (NASDAQ:HNST) stock hit $1.11 on Friday morning, setting a new 52-week low for a change of down 15.6%.
    • ContextLogic (NASDAQ:WISH) shares fell to $4.44 on Friday, setting a new 52-week low with a shift of down 1.74%.
    • Vacasa (NASDAQ:VCSA) stock broke to a new 52-week low of $0.40 on Friday. Shares of the company traded up 1.26%.
    • BioAtla (NASDAQ:BCAB) shares reached a new 52-week low of $2.03 on Friday morning, moving up 0.49%.
    • Sezzle (NASDAQ:SEZL) shares hit a yearly low of $14.01. The stock was down 7.2% on the session.
    • FibroGen (NASDAQ:FGEN) shares set a new yearly low of $0.88 this morning. The stock was down 2.54% on the session.
    • OFS Credit Co (NASDAQ:OCCI) shares made a new 52-week low of $7.26 on Friday. The stock was down 0.71% for the day.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares made a new 52-week low of $3.73 on Friday. The stock was up 0.53% for the day.
    • Clene (NASDAQ:CLNN) shares made a new 52-week low of $0.56 on Friday. The stock was down 5.51% for the day.
    • Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell to $2.80 on Friday, setting a new 52-week low with a shift of down 4.11%.
    • Spectral AI (NASDAQ:MDAI) shares were down 6.3% for the day, having made a 52-week low of $3.60.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock hit a yearly low of $1.22. The stock was down 6.15% for the day.
    • Personalis (NASDAQ:PSNL) shares set a new 52-week low of $1.37. The stock traded down 0.77%.
    • Sol-Gel Technologies (NASDAQ:SLGL) stock set a new 52-week low of $2.16 on Friday, moving down 0.4%.
    • GEN Restaurant Gr (NASDAQ:GENK) shares made a new 52-week low of $12.59 on Friday. The stock was down 3.55% for the day.
    • Eargo (NASDAQ:EAR) stock hit a new 52-week low of $2.44. The stock was up 0.81% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) stock achieved a new 52-week low on Friday morning, hitting $3.41 and moving down 3.94%.
    • Brainstorm Cell (NASDAQ:BCLI) stock hit a yearly low of $0.95. The stock was down 5.0% for the day.
    • Lantern Pharma (NASDAQ:LTRN) shares set a new 52-week low of $4.00. The stock traded down 3.94%.
    • Prestige Wealth (NASDAQ:PWM) stock broke to a new 52-week low of $4.50 on Friday. Shares of the company traded down 4.88%.
    • Leap Therapeutics (NASDAQ:LPTX) stock hit a yearly low of $1.60. The stock was down 2.12% for the day.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPA) shares were down 1.68% for the day, having made a 52-week low of $0.52.
    • Brilliant Earth Group (NASDAQ:BRLT) stock hit a yearly low of $3.07. The stock was down 2.82% for the day.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares reached a new 52-week low of $1.72 on Friday morning, moving down 4.77%.
    • PIMCO New York Municipal (NYSE:PYN) stock achieved a new 52-week low on Friday morning, hitting $5.67 and moving up 0.18%.
    • Solowin Holdings (NASDAQ:SWIN) stock hit a new 52-week low of $2.27. The stock was down 10.04% on the session.
    • Koss (NASDAQ:KOSS) stock broke to a new 52-week low of $3.35 on Friday. Shares of the company traded down 2.31%.
    • RF Industries (NASDAQ:RFIL) shares hit a yearly low of $2.92. The stock was down 18.11% on the session.
    • SEALSQ (NASDAQ:LAES) shares fell to $3.05 on Friday, setting a new 52-week low with a shift of down 6.39%.
    • Sunworks (NASDAQ:SUNW) stock broke to a new 52-week low of $0.68 on Friday. Shares of the company traded down 3.48%.
    • IN8bio (NASDAQ:INAB) shares were down 0.53% for the day, having made a 52-week low of $0.90.
    • OncoCyte (NASDAQ:OCX) shares set a new 52-week low of $3.18. The stock traded up 2.13%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $0.91 on Friday, moving down 2.79%.
    • VBI Vaccines (NASDAQ:VBIV) stock set a new 52-week low of $1.01 on Friday, moving down 2.75%.
    • Protara Therapeutics (NASDAQ:TARA) shares set a new 52-week low of $2.05. The stock traded down 0.45%.
    • Cyngn (NASDAQ:CYN) shares made a new 52-week low of $0.50 on Friday. The stock was down 7.89% for the day.
    • Phoenix New Media (NYSE:FENG) shares reached a new 52-week low of $1.12 on Friday morning, moving down 0.83%.
    • Vaccinex (NASDAQ:VCNX) shares set a new 52-week low of $0.17. The stock traded down 8.97%.
    • EZGO Technologies (NASDAQ:EZGO) shares reached a new 52-week low of $0.16 on Friday morning, moving down 3.61%.
    • PolyPid (NASDAQ:PYPD) shares fell to $0.24 on Friday, setting a new 52-week low with a shift of down 7.49%.
    • Intrusion (NASDAQ:INTZ) stock achieved a new 52-week low on Friday morning, hitting $0.50 and moving down 4.61%.
    • Talis Biomedical (NASDAQ:TLIS) shares hit a yearly low of $5.79. The stock was down 4.99% on the session.
    • Remark Hldgs (NASDAQ:MARK) shares moved down 1.59% on Friday to hit a new 52-week low of $0.51, drifting down 1.59%.
    • Inhibikase Therapeutics (NASDAQ:IKT) stock broke to a new 52-week low of $1.65 on Friday. Shares of the company traded up 1.19%.
    • BioCardia (NASDAQ:BCDA) shares hit a yearly low of $0.39. The stock was down 0.28% on the session.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $1.61. The stock was down 3.55% on the session.
    • Tempo Automation Holdings (NASDAQ:TMPO) stock dropped to a yearly low on Friday of $0.20. Shares traded down 2.86%.
    • ContraFect (NASDAQ:CFRX) stock hit a new 52-week low of $0.58. The stock was up 0.24% on the session.
    • Super League Enterprise (NASDAQ:SLE) shares set a new yearly low of $1.57 this morning. The stock was down 11.82% on the session.
    • Antelope Ent Hldgs (NASDAQ:AEHL) stock drifted down 6.12% on Friday morning to hit a new 52-week low of $0.30.
    • PaxMedica (NASDAQ:PXMD) shares set a new yearly low of $0.25 this morning. The stock was down 5.84% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $1.03. The stock was up 0.93% for the day.
    • Netcapital (NASDAQ:NCPL) stock broke to a new 52-week low of $0.42 on Friday. Shares of the company traded down 16.89%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $2.11 on Friday morning, moving down 3.77%.
    • Applied UV (NASDAQ:AUVI) shares set a new yearly low of $0.45 this morning. The stock was down 4.26% on the session.
    • Scinai Immunotherapeutics (NASDAQ:SCNI) shares fell to $0.95 on Friday, setting a new 52-week low with a shift of down 15.0%.
    • Baudax Bio (NASDAQ:BXRX) shares set a new 52-week low of $0.34. The stock traded down 2.53%.
    • RiceBran Tech (NASDAQ:RIBT) stock hit a yearly low of $0.45. The stock was down 7.16% for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares were down 4.0% for the day, having made a 52-week low of $0.96.
    • Recruiter.Com Group (NASDAQ:RCRT) shares reached a new 52-week low of $1.42 on Friday morning, moving down 3.9%.
    • Blue Star Foods (NASDAQ:BSFC) stock set a new 52-week low of $0.35 on Friday, moving down 6.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $PLNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PLNT
    $PLRX
    $PMF
    $PML

    CompanyDatePrice TargetRatingAnalyst
    Inhibikase Therapeutics Inc.
    $IKT
    12/26/2025$8.00Buy
    H.C. Wainwright
    FuelCell Energy Inc.
    $FCEL
    12/19/2025$7.00 → $9.00Hold
    TD Cowen
    SEALSQ Corp
    $LAES
    12/18/2025$7.00Overweight
    Cantor Fitzgerald
    Realty Income Corporation
    $O
    12/18/2025$61.00Neutral → Underweight
    Analyst
    Insulet Corporation
    $PODD
    12/16/2025$370.00Outperform
    Evercore ISI
    ResMed Inc.
    $RMD
    12/16/2025$275.00Outperform → Neutral
    Robert W. Baird
    SolarEdge Technologies Inc.
    $SEDG
    12/16/2025$33.00Underweight → Equal-Weight
    Morgan Stanley
    Healthpeak Properties Inc.
    $DOC
    12/16/2025$17.00Buy → Hold
    Jefferies
    More analyst ratings

    $PLNT
    $PLRX
    $PMF
    $PML
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Inhibikase Therapeutics with a new price target

    H.C. Wainwright initiated coverage of Inhibikase Therapeutics with a rating of Buy and set a new price target of $8.00

    12/26/25 8:50:26 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TD Cowen reiterated coverage on FuelCell Energy with a new price target

    TD Cowen reiterated coverage of FuelCell Energy with a rating of Hold and set a new price target of $9.00 from $7.00 previously

    12/19/25 7:59:06 AM ET
    $FCEL
    Industrial Machinery/Components
    Energy

    Cantor Fitzgerald initiated coverage on SEALSQ Corp with a new price target

    Cantor Fitzgerald initiated coverage of SEALSQ Corp with a rating of Overweight and set a new price target of $7.00

    12/18/25 9:11:03 AM ET
    $LAES
    Semiconductors
    Technology

    $PLNT
    $PLRX
    $PMF
    $PML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tower Semiconductor to Attend the 28th Annual Needham Growth Conference

    MIGDAL HAEMEK, Israel, December 29, 2025 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leading foundry of high value analog semiconductor solutions, today announced that its company representatives will participate in the 28th Annual Needham Growth Conference on Tuesday, January 13th and Wednesday, January 14th. The Conference will take place at the Lotte New York Palace Hotel in New York. There will be an opportunity for investors to meet one-on-one with company representatives. Interested investors should contact the conference organizers or email the investor relations team at [email protected]. About Tower Semiconductor Tower Semiconductor Ltd. (NASDAQ/TASE: TSEM), the leading found

    12/29/25 6:00:00 AM ET
    $TSEM
    Semiconductors
    Technology

    Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge

    VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Equity Insider News Commentary – The U.S. oncology market is projected to surge from $81 billion in 2025 to $212 billion by 2034[1], driven by a fundamental shift in how physicians combat cancer's most resistant forms. Targeted therapies and immunotherapies are increasingly offering viable alternatives to chemotherapies that have stood for decades as treatment mainstays[2], replacing blunt cytotoxic approaches with precision mechanisms that attack cancer cells while preserving healthy tissue. This pivot toward precision efficacy drives the investment thesis for GT Biopharma, Inc. (NASDAQ:GTBP), Lyell Immunopharma, Inc. (NASDAQ:

    12/24/25 6:00:00 AM ET
    $CRBU
    $GTBP
    $LYEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Xiao-I Corporation Announces Receipt of Nasdaq Listing Deficiency Notices

    SHANGHAI, Dec. 23, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ:AIXI) (the "Company") today announced that it has received two written notifications from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with certain continued listing requirements for The Nasdaq Global Market. Minimum Bid Price Deficiency On December 16, 2025, the Company received a notice from Nasdaq stating that the Company does not currently satisfy the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1), which requires a minimum closing bid price of $1.00 per share. The notice was based on the Company's American Dep

    12/23/25 5:15:00 PM ET
    $AIXI
    Computer Software: Prepackaged Software
    Technology

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    12/23/25 8:48:33 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO and Treasurer Donlan Daniel P bought $17,396 worth of shares (1,000 units at $17.40), increasing direct ownership by 4% to 25,075 units (SEC Form 4)

    4 - NETSTREIT Corp. (0001798100) (Issuer)

    12/22/25 8:59:55 AM ET
    $NTST
    Real Estate Investment Trusts
    Real Estate

    Large owner Opaleye Management Inc. bought $110,412 worth of Ordinary Shares (2,735 units at $40.37) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    12/19/25 4:05:21 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    12/23/25 8:48:33 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Cabot Anthony converted options into 19,048 shares (SEC Form 4)

    4 - Skillz Inc. (0001801661) (Issuer)

    12/23/25 7:04:21 PM ET
    $SKLZ
    EDP Services
    Technology

    Director Hoffman Henry M. converted options into 3,510 shares, increasing direct ownership by 50% to 10,532 units (SEC Form 4)

    4 - Skillz Inc. (0001801661) (Issuer)

    12/23/25 7:03:01 PM ET
    $SKLZ
    EDP Services
    Technology

    $PLNT
    $PLRX
    $PMF
    $PML
    SEC Filings

    View All

    SEC Form 6-K filed by ZIM Integrated Shipping Services Ltd.

    6-K - ZIM Integrated Shipping Services Ltd. (0001654126) (Filer)

    12/29/25 7:00:01 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    SEC Form 6-K filed by Tower Semiconductor Ltd.

    6-K - TOWER SEMICONDUCTOR LTD (0000928876) (Filer)

    12/29/25 6:05:38 AM ET
    $TSEM
    Semiconductors
    Technology

    SEC Form 6-K filed by XIAO-I Corporation

    6-K - Xiao-I Corp (0001935172) (Filer)

    12/23/25 5:20:06 PM ET
    $AIXI
    Computer Software: Prepackaged Software
    Technology

    $PLNT
    $PLRX
    $PMF
    $PML
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    Cambium Networks Announces Compliance with Minimum Bid Price Rule and Appointment of Interim Chief Financial Officer

    HOFFMAN ESTATES, Ill., Dec. 18, 2025 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks", "Cambium" or the "Company") (NASDAQ:CMBM), a leading global provider of networking solutions, announced today that on December 12, 2025, the Company received a partial compliance letter ("Partial Compliance Letter") from the Nasdaq Hearings Panel (the "Hearings Panel") confirming that the Company is in compliance with the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule"), although it remains non-compliant with the Nasdaq Listing Rule 5250(c)(1) (the "Periodic Filing Rule"). The Hearings Panel also confirmed that it will maintain jurisdiction over the Company until April 8, 2026.

    12/18/25 6:15:00 AM ET
    $CMBM
    Radio And Television Broadcasting And Communications Equipment
    Technology

    PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

    PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. "Brooke's appointment marks an exciting and pivotal moment for PolyPid," said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. "Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transfor

    12/16/25 8:30:00 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Financials

    Live finance-specific insights

    View All

    FuelCell Energy Ends FY2025 with Revenue Growth and a Focus on Data Center Opportunities

    Fourth Quarter Fiscal 2025 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $55.0 million, compared to $49.3 million, an increase of approximately 12%Gross loss of $(6.6) million, compared to $(10.9) million, a decrease of approximately 39%Loss from operations of $(28.3) million, compared with $(41.0) million, a decrease of approximately 31%Net loss per share attributable to common stockholders was $(0.85), compared with $(2.21)Backlog of $1.19 billion, compared to $1.16 billion, an increase of approximately 2.6% Fiscal Year 2025 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $158.2 million, compared to $112.1 millionGross loss o

    12/18/25 7:30:00 AM ET
    $FCEL
    Industrial Machinery/Components
    Energy

    Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026

    Bristol Myers Squibb (NYSE:BMY) will announce results for the fourth quarter of 2025 on Thursday, February 5, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET. Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call. A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol My

    12/18/25 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Royalty Pharma Acquires Royalty Interest in Nuvalent's Neladalkib and Zidesamtinib for Up to $315 Million

    NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent's neladalkib and zidesamtinib from an undisclosed third party for up to $315 million. Neladalkib and zidesamtinib are next-generation tyrosine kinase inhibitors (TKIs). Neladalkib is in development for patients with ALK mutation-positive non-small cell lung cancer (NSCLC) and zidesamtinib is in development for ROS1 mutation-positive NSCLC. Both therapies are designed to deliver a best-in-class combination of efficacy and tolerability. In November 2025, Nuvalent reported positive pivotal results for neladalkib in TKI pre-treated pati

    12/16/25 7:15:00 AM ET
    $RPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Protara Therapeutics Inc.

    SC 13G - Protara Therapeutics, Inc. (0001359931) (Subject)

    12/17/24 4:02:03 PM ET
    $TARA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuveen Core Plus Impact Fund

    SC 13D/A - Nuveen Core Plus Impact Fund (0001835068) (Subject)

    12/16/24 6:56:51 PM ET
    $NPCT
    Investment Managers
    Finance

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care